Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Hannover Medical School.
Recruitment status was  Active, not recruiting
University of Ulm
Johann Wolfgang Goethe University Hospital
University Hospital Freiburg
Klinikum Augsburg
Humboldt-Universität zu Berlin
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Ghent
Medizinische Universitätsklinik Tübingen
Klinikum Hanover-Siloah Hospital
Ev. Krankenhaus Essen-Werden
Klinikum Wuppertal GmbH
Information provided by:
Hannover Medical School Identifier:
First received: September 13, 2005
Last updated: November 17, 2005
Last verified: September 2005
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):